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Increased risk and related factors of depression
among patients with COPD: a population-based
cohort study
Tzung-Yi Tsai1,2,3, Hanoch Livneh4, Ming-Chi Lu5,6, Pang-Yau Tsai2,7, Pei-Chun Chen8 and Fung-Chang Sung2,7*
Abstract
Background: Depression is a common and mostly undertreated problem in patients with chronic diseases.
However, population-based studies on the association between chronic obstructive pulmonary disease (COPD) and
subsequent depression are limited in Asian populations. This study evaluated the incidence and risk factors of
depression for patients with COPD in Taiwan.
Methods: Using the claims data from the National Health Insurance of Taiwan, we identified 38,010 COPD patients
newly diagnosed in 2000–2004 and 38,010 subjects without COPD frequency, matched by sex, age and index date.
The incidence rate and hazard ratio for depression were estimated by the end of 2008.
Results: The incidence rate of depression was 1.88 folds higher in the COPD cohort than in the non-COPD cohort
(12.2 versus 6.47 per 1,000 person-years, p < 0.0001). The depression risk was the greatest within the first year
following COPD diagnosis and tended to decline with follow-up time. Among COPD patients, multivariate analysis
showed that younger women and low-income patients were at higher risk of depression. Hospitalization and
comorbidities such as hypertension, arthritis, cancer, and heart disease were also significant predictors for
depression risk.
Conclusion: This population-based cohort study demonstrated a strong relationship between COPD and
subsequent depression. These findings could assist healthcare providers to pinpoint individuals with a higher
predisposition to having depression, which could then facilitate the provision of culturally appropriate rehabilitation
within the first year after the diagnosis of COPD.
Keywords: Chronic obstructive pulmonary disease, Depression, Cohort study
Background
Chronic obstructive pulmonary disease (COPD) is charac-
terized by airflow obstruction, which leads to the slow,
progressive symptoms of persistent cough, exertional dys-
pnea, wheezing, and eventually functional impairment [1].
World Health Organization (WHO) has reported in the
Global Burden of Disease Project that approximately 5 of
100 deaths worldwide are associated with COPD [2]. At
this rate, COPD may rank as the third leading cause of
death in the world by 2020 [3]. Given the complex symp-
toms and long duration of COPD, the medical expenses
for curing the disease cannot be ignored. A study by
Menzin et al. [4] found that the average medical expenses
per COPD patient per year was estimated at US$27,656,
which is nearly 4 times higher than the average cost for
patients without COPD (US$7,126). In a review of the fi-
nancial burden of COPD in USA, the authors estimated
that the annual direct medical costs for COPD amounted
to $21.8 billion, and the indirect costs for restricted days,
lost workdays, and productivity were at $17 billion [5].
COPD does not only cause enormous economic burden,
it also triggers subsequent illnesses. The risk of lung can-
cer for COPD patients is more than two folds higher than
for those without the disease [6]. Curkendall et al. also
confirmed that COPD patients have a 60%–80% higher
risk of developing cardiovascular diseases compared with
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the general population [7]. Given the irreversible nature
and unsatisfactory prognostic outcomes, COPD patients
are frequently diagnosed with psychiatric disorders, par-
ticularly depression [8]. A systematic review of 64 studies
on patients with chronic disease concluded that the preva-
lence of depression ranged from 37% to 71% in COPD pa-
tients, figures comparable to or higher than prevalence
rate in patients with other chronic diseases, such as can-
cer, AIDS, heart disease, and renal disease [9]. Depression
not only increases hospitalization and emergency visits by
48% and 77%, respectively, in COPD patients [10], but also
doubles the likelihood of dying from the comorbidities of
COPD-related depression [11]. Therefore, depression has
become a matter of great healthcare concern for COPD
patients and their families.
Studies on COPD-related depression have been con-
ducted mainly on Western populations but rarely for
people of Asian descent [12]. Chinese, in particular,
often consider depression to be a taboo issue and they
may suffer more in terms of emotional distress [13,14].
Previous studies on Chinese COPD patients have fo-
cused on the effect of medical treatments [15], mortality
[16], and the subsequent risk of skin disease following
COPD [17]. In contrast, data related to the psychological
issues, especially depression, among Asian patients with
COPD are limited. Few studies investigating the influen-
cing factor of depression among Chinese COPD patients
have been conducted, but these studies were limited to a
cross-sectional design and small sample sizes [18,19].
We conducted a follow-up study to determine the associ-
ation between depression risk and COPD using claims
data from the National Health Insurance (NHI) of Taiwan
to evaluate the risk of depression in Oriental patients with
COPD. Apart from being a preliminary study of depres-
sion in COPD patients, its findings should be able to help
healthcare providers identify potential cases of having de-
pression and this will allow more efficient interventions to
improve the quality of life for them.
Methods
Data source
In order to remove financial barriers to medical care for
all residents, Taiwan Department of Health launched a
single-payer NHI Program in 1995. At the end of 2008,
over 99% of Taiwan’s population was enrolled in this
program [20]. The National Health Research Institutes
in Taiwan has been responsible to manage the insurance
claims data and established several sets of Longitudinal
Health Insurance Databases (LHID), providing to scien-
tists in Taiwan for research purposes. This study used a
subset of NHI database, which contained the utilization
and enrollment information for a randomly selected of
one million NHI beneficiaries, representing 5% of all
enrollees in Taiwan in 2000. Because a multistage stratified
systematic sampling method was applied, there were no
statistically significantly differences in sex or age between
the sample group and all enrollees [20]. All data files can
be linked with scrambled identifications. Our study was
thus exempted from full review by the Institutional Review
Board (Research Ethnics Committee, Buddhist Dalin Tzu
Chi Hospital).
Study population
Diagnoses in the insurance claims data were coded with
International Classification of Disease, 9th Revision, Clin-
ical Modification (ICD-9-CM). From records in LHID, we
identified patients with COPD among adults newly diag-
nosed during 2000–2004 with the ICD codes of 491, 492,
and 496 as the COPD cohort. To reduce the misclassifica-
tion, we selected patients with at least two diagnosis of
COPD in outpatient visits within 12 months or patients
being admitted to hospital with a primary diagnosis of
COPD during the 5-year period [17,21].
A comparison cohort was randomly selected from the
remaining insured population without COPD. For each
COPD patient, one person free of COPD was selected
frequency matched with sex, age, and the index date of
COPD. After excluding subjects with a history of depres-
sion at the baseline, we identified 38,010 patients with
COPD and 38,010 subjects in non-COPD cohort for
data analysis. All subjects were followed up to the end of
2008 to measure the incidence of depression. We identi-
fied subjects as having depression if they had at least
two treatment claims for depression in outpatient visits
or hospitalization with depression for ICD-9-CM codes
of 296.2, 296.3, 300.4, or 311 during the follow-up
period. Follow-up person-years (PYs) were determined
by calculating the time interval from the entry date to
the earliest of one of the following: a diagnosis of de-
pression, the date of withdrawal from the insurance, or
the date of December 31, 2008.
Demographic variables and comorbidities
The demographic variables used in this study included
age, gender, income for estimating insurance payment,
and urbanization of the subject’s residential area. The
monthly incomes were divided into three levels: ≤NT
$17,880, NT$17,881–$43,900, and ≥NT$43,901. An in-
come of NT$17,880 was the government-stipulated mini-
mum for full-time employees in Taiwan. Urbanization
levels were stratified into three strata, namely urban (levels
1–2), suburban (levels 3–4) and rural (levels 5–7) areas,
based on population density. Level 1 refers to the “most ur-
banized” and level 7 refers to the “least urbanized” commu-
nities [22]. The baseline comorbidity was also identified for
each subject, including hypertension (ICD9-CM 401–405),
arthritis (ICD9-CM 715, 716.90), diabetes (ICD9-CM 250),
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heart disease (ICD9-CM 410–429), chronic kidney disease
(ICD9-CM 585), and cancer (ICD9-CM 140–208).
Statistical analysis
We performed the χ2 test to examine the differences in
demographic characteristics and comorbidities between
the COPD and comparison cohorts. The incidence rate
of depression for the two cohorts was presented with
the number of cases per 1,000 PYs. COPD patients were
further divided into two groups based on initial way of
medical care seeking, and examined the incidence rate
of depression among them. Cox proportional hazards re-
gression analysis was applied to compute the hazard ra-
tio (HR) and 95% confidence intervals (CI) of depression
for COPD compared with the comparison cohort. We
also used multivariate Cox proportional hazards model
to determine the risk factors that might predict depres-
sion and their adjusted hazard ratio (aHR) within the
COPD cohort. We further evaluated whether the relation
between COPD and depression risk differed over time by
sex. All analyses were conducted using SAS version 9.3
(SAS Institute Inc., Cary, NC, USA), and p < 0.05 was
considered significant.
Results
Baseline and depression incidence between two cohorts
Table 1 shows the distributions of the demographic data
and comorbid medical disorders for the COPD and
comparison cohorts. Patients with COPD were more
likely to have a lower monthly income (p < 0.0001), res-
ide in rural areas (p < 0.0001), and suffer comorbidities,
such as hypertension, arthritis, diabetes, heart disease,
chronic kidney disease, and cancer (all p < 0.0001).
Of the total sample of 76,020 patients, 4,109 had inci-
dent depression during the follow-up period. The inci-
dence of depression in the COPD cohort was nearly two
folds higher than that in the comparisons (12.19 vs. 6.47
per 1,000 PYs) with an aHR of 1.88 (95% CI 1.74–1.98;
Table 2). The depression risk was slightly greater for in-
patients than for outpatients with COPD, with aHR of
2.29 (95% CI: 1.98–2.65) and 1.85 (95% CI: 1.74–1.98).
Relative risk of depression among COPD cohorts
The multivariate Cox proportional-hazard regression
analysis estimated the aHR of depression in COPD pa-
tients by demographic status and comorbidity (Table 3).
Age, gender, monthly income and hospitalization were
significantly related to the risk of depression in COPD
patients. Compared with the oldest group (≥70 years
old), the risk of depression was 15% higher for those
aged ≦ 50 years of age; those aged 51–70 also had an
Table 1 Demographic status and comorbidity compared




N = 38010 N = 38010
Age, years n (%) n (%)
<50 11209 (29.5) 11097 (29.2) 0.3245
50–69 14515 (38.2) 14436 (38.0)
≥70 12286 (32.3) 12477 (32.8)
mean (SD) 59.0 (17.1) 59.2 (17.0) 0.1365
Gender 1.0000
Female 16344 (43.0) 16344 (43.0)
Male 21666 (57.0) 21666 (57.0)
Monthly income <0.0001
Low 16787 (44.2) 16338 (43.0)
Median 19109 (50.3) 19757 (52.0)
High 2114 (5.60) 1915 (5.00)
Level of urbanization <0.0001
Urban 21149 (55.9) 20479 (54.1)
Suburban 12327 (32.6) 12465 (32.9)
Rural 4373 (11.6) 4919 (13.0)
Comorbidity
Hypertension 10565 (27.8) 15190 (40.0) <0.0001
Arthritis 6390 (16.8) 9799 (25.8) <0.0001
Diabetes 4474 (11.8) 6027 (15.9) <0.0001
Heart disease 6473 (17.0) 11871 (31.2) <0.0001
Chronic kidney disease 601 (1.60) 903 (2.40) <0.0001
Cancer 1591 (4.20) 2480 (6.50) <0.0001
Table 2 Crude and adjusted hazard ratios of depression for outpatients and inpatients of COPD compared with non-
COPD controls
Patient group Event PY Incidence Crude HR aHR*
(95% CI) (95% CI)
Controls 1477 228176 6.47 1.00 1.00
COPD patients 2632 215852 12.19 1.88 (1.76–2.00) 1.88 (1.77–2.01)
COPD outpatient 2418 202437 11.94 1.85 (1.73–1.97) 1.85 (1.74–1.98)
COPD inpatient 214 13415 15.95 2.40 (2.08–2.77) 2.29 (1.98–2.65)
Per 1,000 person-years for incidence rate.
*Model adjusted for age, sex, urbanization level, income, and the comorbidity.
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excess risk of 11%. Female sex was related to an aHR of
1.19 for depression, as compared to male. With regard
to monthly income, aHR compared to the subjects with
high monthly income was 1.09 for those with median
monthly income, and 1.23 for those with low monthly
income. Furthermore, the aHR was 1.16 times greater
for COPD inpatients than COPD outpatients. Comor-
bidity increased the depression risk, with the highest risk
for those with heart disease (aHR 1.47, 95% CI 1.35–
1.61), followed by those with arthritis (aHR 1.32, 95% CI
Table 3 Multivariate Cox proportional hazards regression analysis measures the risk of depression among COPD
patients
Variable Number of depression Incidence per 1,000person-years
Crude HR aHR*
(95% CI) (95% CI)
Age
<50 770 10.91 0.80 (0.72–0.88) 1.15 (1.02–1.28)
50–69 1043 12.01 0.91 (0.83–1.00) 1.11 (1.01–1.23)
≥70 819 14.02 1.00 1.00
Gender
Female 1305 13.64 1.23 (1.15–1.33) 1.19 (1.10–1.28)
Male 1327 11.04 1.00 1.00
Monthly income
Low 1189 13.14 1.41 (1.16–1.72) 1.23 (1.01–1.67)
Median 1333 11.75 1.11 (1.03–1.20) 1.09 (1.00–1.18)
High 110 9.25 1.00 1.00
Level of urbanization
Urban 1473 12.34 1.00 1.00
Suburban 821 11.80 0.95 (0.88–1.04) 0.95 (0.87–1.04)
Rural 328 12.60 1.01 (0.90–1.14) 0.98 (0.87–1.11)
Hospitalization
Outpatients 2418 11.94 1.00 1.00
Inpatient 214 15.95 1.29 (1.12–1.48) 1.16 (1.01–1.34)
Comorbidity
Hypertension
No 1470 10.72 1.00 1.00
Yes 1162 14.76 1.35 (1.25–1.46) 1.12 (1.03–1.23)
Arthritis
No 1795 10.91 1.00 1.00
Yes 837 16.33 1.47 (1.36–1.60) 1.32 (1.21–1.44)
Diabetes
No 2180 11.71 1.00 1.00
Yes 452 15.24 1.27 (1.15–1.41) 1.10 (0.99–1.23)
Heart disease
No 1619 10.35 1.00 1.00
Yes 1013 17.03 1.61 (1.49–1.75) 1.47 (1.35–1.61)
Chronic kidney disease
No 2571 12.10 1.00 1.00
Yes 61 17.75 1.41 (1.09–1.81) 1.14 (0.88–1.47)
Cancer
No 2462 11.98 1.00 1.00
Yes 170 16.54 1.34 (1.15–1.56) 1.24 (1.06–1.45)
*Adjusted for all variables in the model.
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1.21–1.44), cancer (aHR 1.24, 95% CI 1.06–1.45), and
hypertension (aHR 1.12, 95% CI 1.03–1.23).
Additionally, we found the risk of depression across the
period following COPD diagnosis was 2.01 (95% CI: 1.72–
2.32) in year one. The aHR decreased with follow-up time
to 1.40 (95% CI: 1.22–1.60) after year 5 (Table 4). The sex-
specific patterns during the follow-up period were similar
for males and females, but higher for females.
Discussion
Previous studies have shown that emotional impairments,
depression in particular, are common among COPD pa-
tients, but mainly in Western populations. To the best of
our knowledge, the present study is the first population-
based cohort study addressing the association between
COPD and the risk of subsequent depression in an Asian
population. The results are consistent with findings in
previous studies on Western populations [8,23,24]. The
likely explanation for this finding was as follows. COPD
patients may require more daily care due to gradually
worsening physical conditions, which may lower self-
esteem and self-efficacy, inducing a higher risk of depres-
sion [9]. Schane et al. found that COPD patients of lower
education, living alone and female gender were more
likely to have depression [8]. A cross-sectional study in
China also found low income COPD patients are more
likely depressive [25]. Our study revealed similar socioeco-
nomic association, indicating the elderly and low income
COPD patients are at higher risk of depression.
Additionally, the same debilitating and continuous phys-
ical symptoms may also trigger cognitions of “learned
helplessness”, such that one’s inability to successfully cope
with physical deterioration and life threatening situations
result in increased levels of uncertainty, unpredictability
and ultimately emotional distress and depression [26]. On
the other hand, several inflammatory cytokines, such as
tumor necrosis factor-α (TNF-α) or interleukin-6 (IL-6),
have been considered pathogenic factors associated with
the mechanism of developing depression [27]. A meta-
analysis containing 24 studies indicated that the inflam-
matory cytokines may regulate adult neurogenesis to
induce hippocampal neurogenesis atrophy, which has
been implicated as a key contributing mechanism in the
pathophysiology and treatment of depression [28].
The depression incidence among COPD patients in
this study is somewhat lower than that in a previous
report [24]. The difference may stem from the different
composition of the two groups of participants. In addition,
the stigma of mental illness is particularly entrenched in
Asian patients and they may be unwilling to acknowledge
or admit feelings of depression [13]. Depression, in many
Asian countries, is an embarrassing issue for the general
population to openly seek regular psychotherapy. Most
importantly, less than 20% of patients with COPD have
ever received appropriate psychiatric treatment since they
were diagnosed with COPD [19]. Therefore, the imple-
mentation of a standardized care process, including some
screening tools applicable to COPD patients, may be of
utmost importance.
Our study indicated that women are at a 1.19-fold
greater risk of depression than men in the COPD cohort,
which supports the findings of previous studies [8,24].
Two reasons may account for this phenomenon. First,
women are more health consciousness than men and
more likely to seek medical care during irregularities in
their well-being [29]. Moreover, women are traditionally
more obedient, passive, and emotional, which may in-
sidiously elevate the risk of depression [30]. In contrast,
our finding contradicts those reported by van Manen
et al. [31]. A small sample size of 162 subjects used in
their study may lead to a null association between the
depression risk and gender.
We found a lower risk of depression in patients with
higher monthly incomes than in those with lower
monthly incomes, which is in line with previous studies
[30,32]. Patients with higher incomes may have better fi-
nancial resources in dealing with the challenges engen-
dered by COPD. This result, however, is inconsistent
with that reported by Lin et al. [33], which may stem
from the use of a different study design. Given that
establishing a clear causality with the cross-sectional
design is difficult, erroneously determining the effect of
risk factors is possible [34].
Table 4 Sex-specific hazard ratios of depression in COPD





Event Rate Event Rate (95% CI)
Total
Year <1 262 7.02 607 16.68 2.01 (1.72-2.32)
Year 1–3 484 6.83 842 12.55 1.66 (1.48-1.87)
Year 3–5 373 5.26 662 9.97 1.65 (1.45-1.89)
After year 5 358 6.37 521 9.81 1.40 (1.22-1.60)
Female
Year <1 112 5.27 318 15.44 2.44 (1.96-3.04)
Year 1–3 220 5.48 433 11.53 1.92 (1.62-2.26)
Year 3–5 193 6.26 316 8.55 1.63 (1.35-1.97)
After year 5 149 4.73 260 8.91 1.70 (1.38-2.09)
Male
Year <1 150 9.32 289 18.30 1.86 (1.40-2.19)
Year 1–3 264 8.61 409 13.86 1.67 (1.36-2.04)
Year 3–5 180 4.49 346 11.76 1.45 (1.24-1.71)
After year 5 209 8.46 261 10.90 1.17 (0.97-1.42)
*Adjusted for age, sex, urbanization level, income, and comorbidity.
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Consistent with previous studies [8,18,31], we found
that younger COPD patients were at a higher hazard for
depression than the elderly. Most of the young COPD
patients were employed; therefore their workload may
have contributed to additional emotional distress. More
importantly, our results demonstrated that the incidence
of depression is higher in COPD inpatients than in out-
patients. This finding indicates that severe COPD, which
requires hospitalization, may trigger an increased risk of
depression. Similar to previous report [35], we also noted
that the risk of depression in COPD patients was higher
within one year after diagnosis. The newly diagnosed pa-
tients may be highly fragile and overwhelmed by COPD
symptoms. These findings suggest that healthcare pro-
viders need to pay closer attention to newly diagnosed
patients with COPD, particularly inpatients. Interven-
tions geared toward providing emotional support to en-
hance the psychological adjustment of patients may be
of utmost importance.
COPD patients with other comorbidities, such as
hypertension, arthritis, heart disease, or cancer had a
significantly higher risk of depression, whereas those
with diabetes mellitus and chronic kidney disease were
at borderline significance. Our findings are partially
paralleled with those of a previous study [8], indicating
that comorbidities are associated with the predisposition
for depression among COPD patients. The occurrence of
comorbidities could play a role in weakening the percep-
tions of health status among COPD patients, thus leading
to increased risk of depression. Additionally, a review art-
icle demonstrated that a depressive mood might be related
to medication, such as antihypertensive agents, corticoste-
roids, or other biological agents [36]. So it was suggested
that clinicians should actively assess existing medications
prior to initiating depression-related treatments for COPD
patients, which may reduce the risk of depression after
COPD diagnosis.
Several limitations in this study should be mentioned.
First, information on tobacco use, social network rela-
tionships, religious belief, and education level was un-
available from the claims data, which may be related to
depression. Further study linking administrative data
and the above mentioned information is warranted to
examine the impact of these potential confounding vari-
ables on depression. Second, inaccurate diagnoses may
occur. Therefore, we selected only those subjects with
COPD or depression with at least two consistent out-
patient visits or one inpatient admission to minimize this
error. Furthermore, NHI has randomly sampled claims
from hospitals and randomly interviewed patients, as well
as reviewed medical charts to verify the accuracy of med-
ical records. Finally, data regarding the severity of COPD,
such as lung function data, were not available in the data-
base. We were unable to estimate the dose–response
relations between COPD severity and depression. Despite
these methodological concerns, this population-based
cohort study has been successful in examining the rela-
tionship between COPD and the subsequent risk of
depression among Chinese patients. The retrospective co-
hort study design per se provided stronger evidence on
the relationship between COPD and depression risk com-
pared with previous studies.
Conclusions
Findings from this study reveal that the depression risk
is nearly two folds higher for COPD patients than for
general population. The risk of depression is related to
being female and young, as well as with lower monthly
income and comorbidity, such as hypertension, arthritis,
cancer, and heart disease. Healthcare providers could be
able to better understand the demographic and diseases
characteristics that may contribute to the depression risk
from this population-based study. The need to routinely
screen COPD patients for depression and institute cul-
turally appropriate interventions should be emphasized,
especially within the first year since COPD diagnosis.
Healthcare providers must be cognizant of the existence
of depression among COPD patients and inform them
by standard care process to avoid potential embarrass-
ment when discussing psychiatric-related issues; this will
help to achieve better therapeutic outcomes for them.
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